FindTrial
Sign In

Botulinum Toxin Type A for Injection

DRUG5 trials

Sponsors

Lanzhou Institute of Biological Products Co., Ltd, The First Affiliated Hospital of Zhengzhou University

Conditions

Brain Stem InfarctionsCerebrovascular AccidentChronic MigraineCricopharyngeal AchalasiaDysphagiaDysphagia, EsophagealDysphagia, OropharyngealOveractive Bladder

Phase 3

A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity
CompletedNCT02280083
Lanzhou Institute of Biological Products Co., LtdCerebrovascular Accident
Start: 2014-07-31End: 2016-09-30Updated: 2016-09-26
A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine
NCT02291380
Lanzhou Institute of Biological Products Co., LtdChronic Migraine
Start: 2014-09-30End: 2020-06-30Target: 288Updated: 2018-01-03
A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)
NCT02786407
Lanzhou Institute of Biological Products Co., LtdOveractive Bladder
Start: 2016-03-31End: 2019-12-31Target: 216Updated: 2018-01-03

Unknown Phase

Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction
RecruitingNCT06196606
The First Affiliated Hospital of Zhengzhou UniversityBrain Stem Infarctions, Dysphagia, Esophageal, Dysphagia, Oropharyngeal
Start: 2022-11-11End: 2024-12-12Target: 20Updated: 2024-05-14
Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia
RecruitingNCT06213662
The First Affiliated Hospital of Zhengzhou UniversityCricopharyngeal Achalasia, Dysphagia
Start: 2022-11-01End: 2024-07-01Target: 20Updated: 2024-05-16